"Pulmonary embolism is fundamentally a cardiovascular disease, where restoration of hemodynamic stability, beyond simple clot removal, is the key determinant of patient recovery,” one researcher explained.
Cardiac amyloidosis continues to get more and more attention at cardiology meetings. At Heart Failure 2026 in Spain, it was the topic of multiple studies, including one on the benefits of acoramidis.
The new guideline calls for a “stepwise approach," followed by close clinical surveillance, when treating uncomplicated TBAD. In some cases, however, earlier endovascular treatments may be necessary.
Artificial intelligence also played a large role in discovering how this intricate network of muscle fibers can influence health, experts explained in Nature.
